Abordaje farmacológico de la gonorrea en mujeres víctimas de violencia sexual en el primer nivel de atención sanitaria

Abstract

Introduction: Rape is defined as penetration, no matter how slight, through the vagina or anus with any part of the body or object, or oral penetration by a sexual organ of another person, without the consent of the victim; As a result, sexually transmitted diseases could develop and among these we find gonorrhea, caused by the gram-negative bacteria Neisseria gonorrhoeae. Objective: to describe the pharmacological approach to gonorrhea in women victims of sexual violence through a systematic review of the literature for the prevention of this pathology in the first level of health care. Materials and methods: Descriptive, retrospective study obtained in databases such as: PubMed, Scopus, Scielo, Google Scholar and Cochrane, from the last 5 years. Results: 19 articles postulated in the first quartile of scientific evidence, 2 in the second quartile, 4 in the fourth quartile, 2 WHO/PAHO official sources and 2 guidelines from Ecuador were included. Conclusions: Worldwide, the pharmacological management of gonorrhea in women victims of sexual violence at the first level of health care should begin with ceftriaxone in a single dose, in clear agreement with the MSP clinical practice guide, where it addresses the management of gonorrhea in Ecuador.